Europe Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity

May 2020 | 123 pages | ID: E567E1C7B69DEN
GMD Research

Abstracts

Europe artificial intelligence (AI) in drug discovery market reached $108.6 million in 2019 and will grow by 28.7% over 2020-2026 owing to the rising need for AI technology in drug discovery and development.

Highlighted with 37 tables and 54 figures, this 123-page report “Europe Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Europe market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Europe AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country.
Based on offering, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Software
• Service

Based on technology, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Deep Learning
• Supervised Learning
• Reinforcement Learning
• Unsupervised Learning
• Other Technologies

Based on drug type, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Large-molecule Drugs
• Small-molecular Drugs

Based on therapeutic area, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Oncology
• Neurodegenerative Diseases
• Cardiovascular Disease
• Metabolic Diseases
• Other Therapeutic Areas

Based on application, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Information & Data Analysis
• Drug Design
• Drug Evaluation
• Clinical Trials
• Other Applications

Based on end user, the Europe market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Contract Research Organizations

Geographically, the following national/local markets are fully investigated:

• Germany
• UK
• France
• Spain
• Italy
• Russia
• Rest of Europe (further segmented into Belgium, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)

For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in Europe AI in drug discovery market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF EUROPE MARKET BY OFFERING

3.1 Market Overview by Offering
3.2 Software
3.3 Service

4 SEGMENTATION OF EUROPE MARKET BY TECHNOLOGY

4.1 Market Overview by Technology
4.2 Deep Learning
4.3 Supervised Learning
4.4 Reinforcement Learning
4.5 Unsupervised Learning
4.6 Other Technologies

5 SEGMENTATION OF EUROPE MARKET BY DRUG TYPE

5.1 Market Overview by Drug Type
5.2 Large-molecule Drugs
5.3 Small-molecular Drugs

6 SEGMENTATION OF EUROPE MARKET BY THERAPEUTIC AREA

6.1 Market Overview by Therapeutic Area
6.2 Oncology
6.3 Neurodegenerative Diseases
6.4 Cardiovascular Disease
6.5 Metabolic Diseases
6.6 Other Therapeutic Areas

7 SEGMENTATION OF EUROPE MARKET BY APPLICATION

7.1 Market Overview by Application
7.2 Information & Data Analysis
7.3 Drug Design
7.4 Drug Evaluation
7.5 Clinical Trials
7.6 Other Applications

8 SEGMENTATION OF EUROPE MARKET BY END USER

8.1 Market Overview by End User
8.2 Pharmaceutical & Biotechnology Companies
8.3 Academic & Research Institutes
8.4 Contract Research Organizations

9 EUROPEAN MARKET 2019-2026 BY COUNTRY

9.1 Overview of European Market
9.2 UK
9.3 France
9.4 Germany
9.5 Spain
9.6 Italy
9.7 Russia
9.8 Rest of European Market

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.

11 INVESTING IN EUROPE MARKET: RISK ASSESSMENT AND MANAGEMENT

11.1 Risk Evaluation of Europe Market
11.2 Critical Success Factors (CSFs)
Related Reports and Products

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Europe AI in Drug Discovery Market, 2019-2026
Table 2. Main Product Trends and Market Opportunities in Europe AI in Drug Discovery Market
Table 3. Europe AI in Drug Discovery Market by Offering, 2015-2026, $ mn
Table 4. Europe AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 5. Europe AI in Drug Discovery Market by Drug Type, 2015-2026, $ mn
Table 6. Europe AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 7. Selected Drug Development Pipelines Aided by AI
Table 8. Europe AI in Drug Discovery Market by Application, 2015-2026, $ mn
Table 9. Europe AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 10. Europe AI in Drug Discovery Market by Country, 2015-2026, $ mn
Table 11. UK AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 12. UK AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 13. UK AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 14. France AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 15. France AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 16. France AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 17. Germany AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 18. Germany AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 19. Germany AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 20. Spain AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 21. Spain AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 22. Spain AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 23. Italy AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 24. Italy AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 25. Italy AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 26. Russia AI in Drug Discovery Market by Technology, 2015-2026, $ mn
Table 27. Russia AI in Drug Discovery Market by Therapeutic Area, 2015-2026, $ mn
Table 28. Russia AI in Drug Discovery Market by End User, 2015-2026, $ mn
Table 29. AI in Drug Discovery Market in Rest of Europe by Country, 2015-2026, $ mn
Table 30. Use Cases of AI for Drug Discovery by Selected Pharmaceutical Companies
Table 31. Atomwise, Inc.: Company Snapshot
Table 32. Atomwise, Inc.: Business Segmentation
Table 33. Atomwise, Inc.: Product Portfolio
Table 34. Atomwise, Inc.: Revenue, 2016-2018, $ mn
Table 35. Atomwise, Inc.: Recent Developments
Table 36. Risk Evaluation for Investing in Europe Market, 2019-2026
Table 37. Critical Success Factors and Key Takeaways

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Breakdown of Primary Research
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 4. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026
Figure 5. Europe AI in Drug Discovery Market, 2019-2026, $ mn
Figure 6. Primary Drivers and Impact Factors of Europe AI in Drug Discovery Market
Figure 7. Primary Restraints and Impact Factors of Europe AI in Drug Discovery Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Europe AI in Drug Discovery Market
Figure 10. Breakdown of Europe AI in Drug Discovery Market by Offering, 2019-2026, % of Revenue
Figure 11. Contribution to Europe 2020-2026 Cumulative Revenue by Offering, Value ($ mn) and Share (%)
Figure 12. Europe AI in Drug Discovery Market: Software, 2015-2026, $ mn
Figure 13. Europe AI in Drug Discovery Market: Service, 2015-2026, $ mn
Figure 14. Breakdown of Europe AI in Drug Discovery Market by Technology, 2019-2026, % of Revenue
Figure 15. Contribution to Europe 2020-2026 Cumulative Revenue by Technology, Value ($ mn) and Share (%)
Figure 16. Europe AI in Drug Discovery Market: Deep Learning, 2015-2026, $ mn
Figure 17. Europe AI in Drug Discovery Market: Supervised Learning, 2015-2026, $ mn
Figure 18. Europe AI in Drug Discovery Market: Reinforcement Learning, 2015-2026, $ mn
Figure 19. Europe AI in Drug Discovery Market: Unsupervised Learning, 2015-2026, $ mn
Figure 20. Europe AI in Drug Discovery Market: Other Technologies, 2015-2026, $ mn
Figure 21. Breakdown of Europe AI in Drug Discovery Market by Drug Type, 2019-2026, % of Revenue
Figure 22. Contribution to Europe 2020-2026 Cumulative Revenue by Drug Type, Value ($ mn) and Share (%)
Figure 23. Europe AI in Drug Discovery Market: Large-molecule Drugs, 2015-2026, $ mn
Figure 24. Europe AI in Drug Discovery Market: Small-molecular Drugs, 2015-2026, $ mn
Figure 25. Breakdown of Europe AI in Drug Discovery Market by Therapeutic Area, 2019-2026, % of Revenue
Figure 26. Contribution to Europe 2020-2026 Cumulative Revenue by Therapeutic Area, Value ($ mn) and Share (%)
Figure 27. Europe AI in Drug Discovery Market: Oncology, 2015-2026, $ mn
Figure 28. Europe AI in Drug Discovery Market: Neurodegenerative Diseases, 2015-2026, $ mn
Figure 29. Europe AI in Drug Discovery Market: Cardiovascular Disease, 2015-2026, $ mn
Figure 30. Europe AI in Drug Discovery Market: Metabolic Diseases, 2015-2026, $ mn
Figure 31. Europe AI in Drug Discovery Market: Other Therapeutic Areas, 2015-2026, $ mn
Figure 32. Breakdown of Europe AI in Drug Discovery Market by Application, 2019-2026, % of Revenue
Figure 33. Contribution to Europe 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%)
Figure 34. Europe AI in Drug Discovery Market: Information & Data Analysis, 2015-2026, $ mn
Figure 35. Europe AI in Drug Discovery Market: Drug Design, 2015-2026, $ mn
Figure 36. Europe AI in Drug Discovery Market: Drug Evaluation, 2015-2026, $ mn
Figure 37. Europe AI in Drug Discovery Market: Clinical Trials, 2015-2026, $ mn
Figure 38. Europe AI in Drug Discovery Market: Other Applications, 2015-2026, $ mn
Figure 39. Breakdown of Europe AI in Drug Discovery Market by End User, 2019-2026, % of Revenue
Figure 40. Contribution to Europe 2020-2026 Cumulative Revenue by End User, Value ($ mn) and Share (%)
Figure 41. Europe AI in Drug Discovery Market: Pharmaceutical & Biotechnology Companies, 2015-2026, $ mn
Figure 42. Europe AI in Drug Discovery Market: Academic & Research Institutes, 2015-2026, $ mn
Figure 43. Europe AI in Drug Discovery Market: Contract Research Organizations, 2015-2026, $ mn
Figure 44. Breakdown of European AI in Drug Discovery Market by Country, 2019 and 2026, % of Revenue
Figure 45. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)
Figure 46. AI in Drug Discovery Market in UK, 2015-2026, $ mn
Figure 47. AI in Drug Discovery Market in France, 2015-2026, $ mn
Figure 48. AI in Drug Discovery Market in Germany, 2015-2026, $ mn
Figure 49. AI in Drug Discovery Market in Spain, 2015-2026, $ mn
Figure 50. AI in Drug Discovery Market in Italy, 2015-2026, $ mn
Figure 51. AI in Drug Discovery Market in Russia, 2015-2026, $ mn
Figure 52. AI in Drug Discovery Market in Rest of Europe, 2015-2026, $ mn
Figure 53. Growth Stage of Europe AI in Drug Discovery Industry over the Forecast Period
Figure 54. Share of Developments of Key Vendors by Strategy Type, 2015-2019